XML 50 R40.htm IDEA: XBRL DOCUMENT v3.22.2.2
Fair Value Instruments (Tables)
9 Months Ended
Sep. 30, 2022
Fair Value Disclosures [Abstract]  
Disclosure of Fair Value and Carrying Value of Debt Instruments The estimated fair value, as well as the carrying value, of the Company's debt instruments as of September 30, 2022 and December 31, 2021 are shown below (in millions):

 

 

September 30, 2022

 

 

December 31, 2021

 

Estimated aggregate fair value

 

$

436.1

 

 

$

432.0

 

Aggregate carrying value (1)

 

 

490.4

 

 

 

427.3

 

 

(1) Total debt excluding the impact of unamortized debt discount and debt issuance costs.

Summary of Recurring Measures at Fair Value by Level of Hierarchy

The following table sets forth, by level of hierarchy, the Company’s recurring measures at fair value as of September 30, 2022 and December 31, 2021, which was presented in “Other current liabilities” and “Other liabilities” on the Condensed Consolidated Balance Sheets (amounts in millions):

 

 

September 30, 2022

 

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

Liabilities: contingent consideration

 

$

 

 

$

 

 

$

3.2

 

 

 

 

 

 

 

 

 

 

 

 

 

December 31, 2021

 

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

Liabilities: contingent consideration

 

$

 

 

$

 

 

$

2.8

 

Summary of Changes to Level 3 Instruments

The following is a summary of changes to Level 3 instruments as of September 30, 2022 and December 31, 2021 (amounts in millions):

 

Contingent Consideration

 

Balance, January 1, 2021

$

1.8

 

Acquisition of Ginop

 

0.9

 

Change in fair value

 

0.1

 

Balance, December 31, 2021

$

2.8

 

Acquisition of Ginop adjustment

 

0.3

 

Changes in fair value

 

0.4

 

Payments

 

(0.3

)

Balance, September 30, 2022

$

3.2